{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:50:00Z","timestamp":1761972600817,"version":"build-2065373602"},"reference-count":40,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2025.j043","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T18:06:12Z","timestamp":1743012372000},"page":"245-254","source":"Crossref","is-referenced-by-count":0,"title":["Tenascin C Enhances the Development of Papillary Thyroid Carcinoma and has Diagnostic Significance in Papillary Thyroid Microcarcinoma"],"prefix":"10.1620","volume":"267","author":[{"given":"Qiwei","family":"Du","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The First People\u2019s Hospital of Xiaoshan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrine, The First People\u2019s Hospital of Xiaoshan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The First People\u2019s Hospital of Xiaoshan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The First People\u2019s Hospital of Xiaoshan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The First People\u2019s Hospital of Xiaoshan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, The First People\u2019s Hospital of Xiaoshan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aiello, N.M., Brabletz, T., Kang, Y., Nieto, M.A., Weinberg, R.A.&amp;Stanger, B.Z. (2017)  Upholding a role for EMT in pancreatic cancer metastasis. <i>Nature<\/i>, 547, E7-E8.","DOI":"10.1038\/nature22963"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Brabletz, T., Kalluri, R., Nieto, M.A.&amp;Weinberg, R.A. (2018)  EMT in cancer. <i>Nat. Rev. Cancer<\/i>, 18, 128-134.","DOI":"10.1038\/nrc.2017.118"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Brito, J.P.&amp;Hay, I.D. (2019)  Management of Papillary Thyroid Microcarcinoma. <i>Endocrinol. Metab. Clin. North Am<\/i>., 48, 199-213.","DOI":"10.1016\/j.ecl.2018.10.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cai, J., Du, S., Wang, H., Xin, B., Wang, J., Shen, W., Wei, W., Guo, Z.&amp;Shen, X. (2017)  Tenascin-C induces migration and invasion through JNK\/c-Jun signalling in pancreatic cancer. <i>Oncotarget<\/i>, 8, 74406-74422.","DOI":"10.18632\/oncotarget.20160"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ci, X., Hao, J., Dong, X., Xue, H., Wu, R., Choi, S.Y.C., Haegert, A.M., Collins, C.C., Liu, X., Lin, D.&amp;Wang, Y. (2020)  Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development. <i>Cells<\/i>, 9, 1398.","DOI":"10.3390\/cells9061398"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Donovan, C., Bai, X., Chan, Y.L., Feng, M., Ho, K.F., Guo, H., Chen, H.&amp;Oliver, B.G. (2023) Tenascin C in Lung Diseases. <i>Biology<\/i> (<i>Basel<\/i>), 12, 199.","DOI":"10.3390\/biology12020199"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fischer, K.R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S.T., Choi, H., El Rayes, T., Ryu, S., Troeger, J., Schwabe, R.F., Vahdat, L.T., Altorki, N.K., Mittal, V.&amp;Gao, D. (2015)  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. <i>Nature<\/i>, 527, 472-476.","DOI":"10.1038\/nature15748"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Gebauer, F., Gelis, S., Zander, H., Meyer, K.F., Wolters-Eisfeld, G., Izbicki, J.R., Bockhorn, M.&amp;Tachezy, M. (2016)  Tenascin-C serum levels and its prognostic power in non-small cell lung cancer. <i>Oncotarget<\/i>, 7, 20945-20952.","DOI":"10.18632\/oncotarget.7976"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Guan, Z., Sun, Y., Mu, L., Jiang, Y.&amp;Fan, J. (2022)  Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-kappaB signaling activation. <i>BMC Cancer<\/i>, 22, 240.","DOI":"10.1186\/s12885-022-09285-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hasegawa, M., Yoshida, T.&amp;Sudo, A. (2018)  Role of tenascin-C in articular cartilage. <i>Mod. Rheumatol<\/i>., 28, 215-220.","DOI":"10.1080\/14397595.2017.1349560"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Janssen, S., Huson, M.A., Osbak, K.K., Rossatanga, E.G., Alabi, A., Lutter, R., Grobusch, M.P.&amp;van der Poll, T. (2017)  HIV infection rather than concurrent opportunistic infections drives most systemic procoagulant, vascular and damage responses - a prospective cohort study in central Africa. <i>Antivir. Ther<\/i>., 22, 153-161.","DOI":"10.3851\/IMP3100"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kang, X., Xu, E., Wang, X., Qian, L., Yang, Z., Yu, H., Wang, C., Ren, C., Wang, Y., Lu, X., Xia, X., Guan, W.&amp;Qiao, T. (2021)  Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT. <i>Cell Death Dis<\/i>., 12, 890.","DOI":"10.1038\/s41419-021-04153-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Koperek, O., Bergner, O., Pichlhofer, B., Oberndorfer, F., Hainfellner, J.A., Kaserer, K., Horvat, R., Harris, A.L., Niederle, B.&amp;Birner, P. (2011)  Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene. <i>J. Pathol<\/i>., 225, 63-72.","DOI":"10.1002\/path.2926"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kopustinskiene, D.M., Jakstas, V., Savickas, A.&amp;Bernatoniene, J. (2020)  Flavonoids as Anticancer Agents. <i>Nutrients<\/i>, 12, 457.","DOI":"10.3390\/nu12020457"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Krebs, A.M., Mitschke, J., Lasierra Losada, M., Schmalhofer, O., Boerries, M., Busch, H., Boettcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., Brunton, V.G., Pilarsky, C., Winkler, T.H., Brabletz, S., Stemmler, M.P., et al.(2017)  The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. <i>Nat. Cell Biol<\/i>., 19, 518-529.","DOI":"10.1038\/ncb3513"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kuburich, N.A., den Hollander, P., Pietz, J.T.&amp;Mani, S.A. (2022)  Vimentin and cytokeratin: Good alone, bad together. <i>Semin. Cancer Biol<\/i>., 86, 816-826.","DOI":"10.1016\/j.semcancer.2021.12.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Lam, A.K. (2022)  Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification. <i>Methods Mol. Biol<\/i>., 2534, 1-15.","DOI":"10.1007\/978-1-0716-2505-7_1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lee, Y.C., Lin, S.C., Yu, G., Zhu, M., Song, J.H., Rivera, K., Pappin, D.J., Logothetis, C.J., Panaretakis, T., Wang, G., Yu-Lee, L.Y.&amp;Lin, S.H. (2022)  Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP\/TAZ inhibition. <i>Oncogene<\/i>, 41, 757-769.","DOI":"10.1038\/s41388-021-02131-7"},{"key":"19","unstructured":"Limaiem, F., Rehman, A.&amp;Mazzoni, T. (2023) Papillary Thyroid Carcinoma. <i>In StatPearls<\/i>, StatPearls Publishing, Treasure Island (FL)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Midwood, K.S., Hussenet, T., Langlois, B.&amp;Orend, G. (2011)  Advances in tenascin-C biology. <i>Cell. Mol. Life Sci<\/i>., 68, 3175-3199.","DOI":"10.1007\/s00018-011-0783-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Murdamoothoo, D., Sun, Z., Yilmaz, A., Riegel, G., Abou-Faycal, C., Deligne, C., Velazquez-Quesada, I., Erne, W., Nascimento, M., Morgelin, M., Cremel, G., Paul, N., Carapito, R., Veber, R., Dumortier, H., et al.(2021)  Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. <i>EMBO Mol. Med<\/i>., 13, e13270.","DOI":"10.15252\/emmm.202013270"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Okada, T.&amp;Suzuki, H. (2020)  The Role of Tenascin-C in Tissue Injury and Repair After Stroke. <i>Front. Immunol<\/i>., 11, 607587.","DOI":"10.3389\/fimmu.2020.607587"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Ozanne, J., Shek, B., Stephen, L.A., Novak, A., Milne, E., McLachlan, G., Midwood, K.S.&amp;Farquharson, C. (2022)  Tenascin-C is a driver of inflammation in the DSS model of colitis. <i>Matrix Biol. Plus<\/i>, 14, 100112.","DOI":"10.1016\/j.mbplus.2022.100112"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sarkar, S., Mirzaei, R., Zemp, F.J., Wei, W., Senger, D.L., Robbins, S.M.&amp;Yong, V.W. (2017)  Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells. <i>Cancer Res<\/i>., 77, 3231-3243.","DOI":"10.1158\/0008-5472.CAN-16-2171"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Shash, L.S., Ibrahim, R.A.&amp;Elgohary, S.A. (2021)  E-cadherin and N-cadherin Immunohistochemical Expression in Proliferating Urothelial Lesions: Potential Novel Cancer Predictive EMT Profiles. <i>Appl. Immunohistochem. Mol. Morphol<\/i>., 29, 657-666.","DOI":"10.1097\/PAI.0000000000000940"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Spenl\u00e9, C., Loustau, T., Murdamoothoo, D., Erne, W., Beghelli-de la Forest Divonne, S., Veber, R., Petti, L., Bourdely, P., Morgelin, M., Brauchle, E.M., Cremel, G., Randrianarisoa, V., Camara, A., Rekima, S., Schaub, S., et al.(2020) Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma. <i>Cancer Immunol. Res<\/i>., 8, 1122-1138.","DOI":"10.1158\/2326-6066.CIR-20-0074"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Steiner, F., Hauser-Kronberger, C., Rendl, G., Rodrigues, M.&amp;Pirich, C. (2016)  Expression of Tenascin C, EGFR, E-Cadherin, and TTF-1 in Medullary Thyroid Carcinoma and the Correlation with RET Mutation Status. <i>Int. J. Mol. Sci<\/i>., 17, 1093.","DOI":"10.3390\/ijms17071093"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Steitz, A.M., Steffes, A., Finkernagel, F., Unger, A., Sommerfeld, L., Jansen, J.M., Wagner, U., Graumann, J., Muller, R.&amp;Reinartz, S. (2020)  Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. <i>Cell Death Dis<\/i>., 11, 249.","DOI":"10.1038\/s41419-020-2438-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Tagliabue, M., Giugliano, G., Mariani, M.C., Rubino, M., Grosso, E., Chu, F., Calastri, A., Maffini, F.A., Mauri, G., De Fiori, E., Manzoni, M.F.&amp;Ansarin, M. (2021) Prevalence of Central Compartment Lymph Node Metastases in Papillary Thyroid Micro-Carcinoma: A Retrospective Evaluation of Predictive Preoperative Features. <i>Cancers<\/i> (<i>Basel<\/i>), 13, 6028.","DOI":"10.3390\/cancers13236028"},{"key":"30","unstructured":"Takahashi, Y., Sawada, G., Kurashige, J., Matsumura, T., Uchi, R., Ueo, H., Ishibashi, M., Takano, Y., Akiyoshi, S., Iwaya, T., Eguchi, H., Sudo, T., Sugimachi, K., Yamamoto, H., Doki, Y., et al.(2013)  Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells. <i>Anticancer Res<\/i>., 33, 1927-1934."},{"key":"31","doi-asserted-by":"crossref","unstructured":"Tseleni-Balafouta, S., Gakiopoulou, H., Fanourakis, G., Voutsinas, G., Balafoutas, D.&amp;Patsouris, E. (2006)  Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma. <i>Exp. Mol. Pathol<\/i>., 80, 177-182.","DOI":"10.1016\/j.yexmp.2005.09.006"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, G.&amp;Liu, H. (2022)  Tenascin-C: A Key Regulator in Angiogenesis during Wound Healing. <i>Biomolecules<\/i>, 12, 1689.","DOI":"10.3390\/biom12111689"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Wawrzyniak, D., Grabowska, M., Glodowicz, P., Kuczynski, K., Kuczynska, B., Fedoruk-Wyszomirska, A.&amp;Rolle, K. (2020)  Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. <i>PLoS One<\/i>, 15, e0237889.","DOI":"10.1371\/journal.pone.0237889"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Wei, J., Wu, L., Yang, S., Zhang, C., Feng, L., Wang, M., Li, H.&amp;Wang, F. (2022)  E-cadherin to N-cadherin switching in the TGF-beta1 mediated retinal pigment epithelial to mesenchymal transition. <i>Exp. Eye Res<\/i>., 220, 109085.","DOI":"10.1016\/j.exer.2022.109085"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Wu, X., Li, B.L., Zheng, C.J.&amp;He, X.D. (2020)  Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma. <i>World J. Clin. Cases<\/i>, 8, 1350-1360.","DOI":"10.12998\/wjcc.v8.i8.1350"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Xia, S., Lal, B., Tung, B., Wang, S., Goodwin, C.R.&amp;Laterra, J. (2016)  Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. <i>Neuro. Oncol<\/i>., 18, 507-517.","DOI":"10.1093\/neuonc\/nov171"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Yang, Z., Zhang, C., Qi, W., Cui, C., Cui, Y.&amp;Xuan, Y. (2018)  Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation. <i>Exp. Mol. Pathol<\/i>., 105, 216-222.","DOI":"10.1016\/j.yexmp.2018.08.009"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yilmaz, A., Loustau, T., Salome, N., Poilil Surendran, S., Li, C., Tucker, R.P., Izzi, V., Lamba, R., Koch, M.&amp;Orend, G. (2022)  Advances on the roles of tenascin-C in cancer. <i>J. Cell Sci<\/i>., 135, jcs260244.","DOI":"10.1242\/jcs.260244"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Yonebayashi, S., Tajiri, K., Li, S.&amp;Sato, A. (2020)  Tenascin-C: an emerging prognostic biomarker in diabetes. <i>Ann. Transl. Med<\/i>., 8, 1699.","DOI":"10.21037\/atm-2020-116"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Zhang, P., Liu, G., Hu, J., Chen, S., Wang, B., Peng, P., Yu, X.&amp;Guo, D. (2022)  Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas. <i>Front. Immunol<\/i>., 13, 824586.","DOI":"10.3389\/fimmu.2022.824586"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/267\/2\/267_2025.J043\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:55:12Z","timestamp":1761969312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/267\/2\/267_2025.J043\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j043","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025.J043"}}